|
To,
The Members,
Your Directors take pleasure in presenting the 51st Annual
Report on the business and operations of your Company together with the audited financial
statements for the year ended March 31,2026.
State of the Company's Affairs
Financial Results
The financial performance of your Company is as summarized below:
| Particulars |
Standalone |
Consolidated |
|
2025-26 |
2024-25 |
2025-26 |
2024-25 |
| Revenue from Operations |
21,014.12 |
17,120.70 |
25,007.40 |
20,129.99 |
| Total Expense |
20,142.52 |
16,076.36 |
23,590.49 |
19,100.30 |
| Profit Before Tax |
1,021.01 |
1,919.05 |
1,551.38 |
1,946.10 |
| Profit for the Year |
775.88 |
1,722.36 |
1,289.07 |
1,756.24 |
| Add: Balance as per last year |
12,533.66 |
11,281.99 |
11,738.41 |
10,452.86 |
| Total |
13,309.54 |
13,004.35 |
13,027.48 |
12,209.10 |
| Appropriation |
|
|
|
|
| General Reserves |
- |
- |
- |
- |
| Dividend Paid |
(235.35) |
(470.69) |
(235.35) |
(470.69) |
| Tax on Dividend Paid |
- |
- |
- |
- |
| Balance carried to Balance Sheet |
13,074.20 |
12,533.66 |
12,792.13 |
11,738.41 |
Results of Operations Income
During the year under review, consolidated revenue from operations were
Rs 25,007.40 lakhs as compared to Rs 20,129.99 lakhs in the previous year. On a standalone
basis, your Company's revenues from operations were Rs 21,014.12 lakhs as compared to
Rs 17,120.70 lakhs in the previous year.
Profit Before Tax
Consolidated profits before tax for the current year were Rs 1,551.38
lakhs as against Rs 1,946.10 lakhs in the previous year. On a standalone basis, your
Company's profits before tax for the current year were Rs 1,021.01 lakhs as against
Rs 1,919.05 lakhs in the previous year.
Profit After Tax
Consolidated profit after tax for the current year were Rs 1,289.07
lakhs as against Rs 1,756.24 lakhs in the previous year. On a standalone basis, your
Company's profit after tax for the current year were Rs 775.88 lakhs as against Rs
1,722.36 lakhs in the previous year.
Nature of Business
The Company continues to engage in manufacturing specialty chemicals
like high performance coatings, automotive sealants, metal treatment chemicals,
engineering adhesives, and animal health and industrial biotech products.
Dividend
The Board of Directors have recommended a final dividend of Rs 2.00
(Rupees Two only) per share (40%) for the financial year ended March 31,2026.
Pursuant to the Finance Act, 2020, dividend income is taxable in the
hands of the shareholders effective April 1, 2020 and the Company is required to deduct
tax at source from dividend paid to the Members at prescribed rates as per the Income Tax
Act, 2025.
In accordance with Regulation 43A of the Securities and Exchange Board
of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the
Listing Regulations"), the Board of Directors of the Company have voluntarily adopted
a Dividend Distribution Policy ("Policy") which endeavours for fairness,
consistency and sustainability while distributing profits to the shareholders. Dividend
payout is in accordance with the Policy which is available on the website of the Company
i.e. https://chembond.in/ all-policies/.
Share Capital
The movement of paid-up equity capital is as under:
| Particulars |
No. of Equity Shares |
Equity Share Capital (Rs) |
| Equity Capital as on April 1,2025 |
1,34,48,288 |
6,72,41,440 |
| Increase/ Decrease during the year |
Nil |
Nil |
| Equity Capital as on March 31,2026 |
1,34,48,288 |
6,72,41,440 |
During the year 2025-26, there was no change in the paid-up capital of
the Company.
Your Company has only one class of equity shares and it has neither
issued shares with differential rights for dividend, voting or otherwise, nor issued
shares (including sweat equity shares) to the employees or directors of the Company, under
any Scheme.
No disclosure is required under Section 67(3)(c) of the Companies Act,
2013 ("the Act") in respect of voting rights not exercised directly by the
employees or key managerial personnel of the Company as the provisions of the Section are
not applicable.
Transfer to Reserves
The Board of Directors have decided to retain the entire amount of
profits for FY 2025-26 in the retained earnings. (Previous year Nil)
Deposits
The Company has not accepted any deposits within the meaning of Section
73 of the Act read with the Companies (Acceptance of Deposits) Rules, 2014 as amended from
time to time.
Particulars of Loans, Guarantees and Investments
Details of loans, guarantees and investments have been disclosed in the
Financial Statements.
Subsidiary
Your Company has one subsidiary company namely Chembond Biosciences
Limited.
The details of financial performance of the subsidiary are given in
AOC-I as Annexure 1.
Further, pursuant to the provisions of the Act, the standalone
financial statements of the Company, consolidated financial statements along with relevant
documents and separate audited financial statements in respect of subsidiary, is available
on the Company's website https://chembond.in/subsidiary-financials/.
Promoters
The Promoter Group's holding in the Company as on March 31, 2026
was 68.08% of the Company's paid- up equity capital. The members may note that the
shareholding and other details of Promoters has been provided in the Annual Return.
Directors
The Company acknowledges that a diverse Board is integral to its
sustained growth, long-term success, and effective corporate governance. Board diversity
enriches decision-making by bringing varied perspectives and experiences, enabling a
deeper understanding of stakeholder interests and strengthening risk management practices.
It also promotes innovation, reflects the diversity of the Company's stakeholders,
and contributes positively to its financial performance and corporate reputation.
As of the date of this Report, the Board comprises seven(7) Directors,
including one Non-executive NonIndependent Director, two Executive Directors, and four
Independent Directors, one of whom is a Woman Independent Director. The Chairman of the
Board is an Executive Director.
Appointment of Director
Mr. Jaywant Tawade (DIN: 08231696) was appointed as an Executive
Director of the Company for a period of three (3) years, w.e.f. May 31, 2025 and
shareholders approval was accorded at the 50th Annual General Meeting (AGM)
held on August 14, 2025.
Mr. Kamal Tandon (DIN:09664746) was appointed as an Independent
Director of the Company for a period of five (5) years w.e.f. July 16, 2025 till July 15,
2030 and shareholders approval was accorded at the 50th AGM on August 14, 2025.
Director Retiring by Rotation
In accordance with the provisions of Section 152(6) of the Act, Mr.
Jaywant Tawade (DIN:08231696) Executive Director, retires by rotation and being eligible,
offers himself for re-appointment. His background is given in the Notice, which forms part
of Annual Report.
Inter-se Relationship between Directors
Mr. Sameer Shah, Chairman & Managing Director and Mr. Nirmal Shah,
Non-executive Director are relatives (siblings). Apart from this none of the Directors of
the Company are in any way related to each other.
Declaration by Independent Directors
All the Independent Directors of the Company have furnished a
declaration to the effect that they meet the criteria of independence as provided in
Section 149(6) of the Act and Regulation 16(1)(b) and Regulation 25 of the Listing
Regulations. In the opinion of the Board, all the Independent Directors possess the
integrity, expertise and experience including the proficiency required to be Independent
Directors of the Company, fulfil the conditions of independence as specified in the Act
and the Listing Regulations and are independent of the management and have also complied
with the Code for Independent Directors as prescribed in Schedule IV of the Act.
The Directors also furnished declaration of independence as required
under the Listing Regulations.
Policy on Directors appointment and remuneration
The Company has put in place an appropriate policy on appointment and
remuneration of Directors and other matters provided under Section 178(3) of the Act. This
policy is uploaded on the Company's website https:// chembond.in/all-policies/.
Salient features of the policy on remuneration of Directors have been disclosed in the
Notice of this Annual Report.
Performance Evaluation and Its Criteria
Pursuant to the provisions of the Act and the Corporate Governance
requirements prescribed under the Listing Regulations, the Board of Directors conducted an
annual evaluation of its own performance, the performance of its Committees, and that of
the individual directors for the financial year under review.
The evaluation of the Board and its Committees was carried out after
considering inputs received from the directors and committee members. The assessment
covered various aspects, including the composition and structure of the Board and
Committees, effectiveness of their functioning and decision-making processes, quality and
adequacy of information flow, and overall governance practices. The Board and the
Nomination and Remuneration Committee ("NRC") also evaluated the performance of
individual directors based on parameters such as participation and attendance at meetings,
preparedness, constructive contribution to discussions, and guidance provided on matters
deliberated by the Board and its Committees.
In accordance with the applicable regulatory requirements, the
Independent Directors, at their separate meeting held on February 5, 2026, reviewed and
evaluated the performance of the Non-Independent Directors, the Board as a whole, and the
Executive Directors of the Company. The Independent Directors also assessed the quality,
quantity, and timeliness of information made available to the Board and its Committees and
were satisfied that the information flow was adequate to enable the Directors to
effectively discharge their duties and responsibilities.
Key Managerial Personnel
Pursuant to the provisions of Section 203 of the Act, Mr. Sameer Shah,
Chairman & Managing Director, Mr. Jaywant Tawade, Executive Director, Mrs. Rashmi
Gavli, Chief Financial Officer and Mrs. Suchita Singh, Company Secretary are the Key
Managerial Personnel of the Company as on the date of this Report.
Number of Board Meetings
Six (6) meetings of the Board were held during the year under review,
details of which are furnished in the Corporate Governance Report forming part of the
Annual Report. The maximum gap between two Board Meetings did not exceed 120 days, as
prescribed under the Act.
Audit Committee
The details in respect of role/powers/composition of the Audit
Committee and other information are included in the Corporate Governance Report forming
part of this Annual Report.
Incentive / Commission to Directors
Based on the Company's performance during FY 202526 and pursuant
to the recommendation of the NRC, the Board of Directors, at its meeting held on May 15,
2026, approved an incentive/performance-linked bonus of Rs 50.00 lakhs for Mr. Sameer
Shah. The said amount shall be paid during FY 2026-27.
The NRC also recommended payment of commission to the Non-executive
Directors for FY 2025-26, not exceeding 1% of the net profits of the Company computed in
accordance with Section 198 of the Act. A total sum of Rs 3.60 lakhs collectively to the
Nonexecutive Directors was approved by the Board. The commission shall be paid during FY
2026-27.
Annual Return as on March 31,2026
The Annual Return as provided under Section 92(3) read with Section
134(3)(a) of the Act as prescribed in Form No. MGT-7 of the Companies (Management and
Administration) Rules, 2014, is available on the website of the company at
https://chembond.in/annual- reports/.
Management Discussion and Analysis Report
Management Discussion and Analysis Report for the year under review, as
stipulated under the Listing Regulations, is presented in a separate section, forming part
of this Annual Report.
Corporate Governance & Vigil Mechanism
A separate Report on Corporate Governance, prepared in compliance with
Regulation 34(3) read with Schedule V of the Listing Regulations forms an integral part of
this Annual Report. The report provides a comprehensive overview of the Company's
governance framework, policies, and practices adopted to ensure transparency,
accountability, and ethical business conduct. A certificate from Mr. Virendra G. Bhatt,
Practicing Company Secretary and Secretarial Auditor of the Company, confirming compliance
with the conditions of Corporate Governance as stipulated under the Listing Regulations,
forms part of this Annual Report as Annexure 2.
The Company has established a robust Vigil Mechanism through its
Whistle Blower Policy, which enables Directors and employees to report genuine concerns
relating to unethical behaviour, actual or suspected fraud, violations of the
Company's Code of Conduct, applicable laws, regulations, or internal policies. The
Policy promotes a culture of integrity, transparency, and accountability across the
organization and provides adequate safeguards against victimization of individuals who
raise concerns in good faith. It also facilitates direct access to the Chairperson of the
Audit Committee in appropriate and exceptional circumstances. During the year under
review, the Company continued to strengthen awareness of the vigil mechanism among
employees and encouraged timely reporting of concerns. The Whistle Blower Policy is
available on the Company's website at https://chembond.in/all-policies/.
Risk Management
Pursuant to the requirements of the Listing Regulations, the Company
has constituted a Risk Management Committee to oversee the implementation and
effectiveness of its risk management framework. The Committee is entrusted with, inter
alia, formulating and reviewing the risk management plan, identifying and monitoring
critical risks, apprising the Board of significant changes in the risk profile on an
ongoing basis, reporting critical risks to the Audit Committee annually, and discharging
such other responsibilities as may be assigned by the Board from time to time.
The Company has in place a comprehensive risk management policy and
Plan, which is available on the Company's website at https://chembond.in/all-
policies/. The Committee periodically reviews the Company's risk management framework
and monitors the effectiveness of the mitigation measures adopted.
In the opinion of the Board, no risk has been identified during FY
2025-26 that may materially threaten the existence of the Company. Details of the
composition and meetings of the Risk Management Committee are provided in the Corporate
Governance Report forming part of this Annual Report.
Internal Financial Control System
The Board of Directors is responsible for establishing and maintaining
adequate internal financial controls in accordance with the provisions of Section 134 of
the Act.
The Company has in place a comprehensive and effective internal control
framework designed to ensure orderly and efficient conduct of its business operations,
adherence to the Company's policies and procedures, safeguarding of assets,
prevention and detection of frauds and errors, accuracy and completeness of accounting
records, and timely preparation of reliable financial information. The internal financial
control system is commensurate with the size, scale, nature, geographical spread and
complexity of the Company's operations and is regularly reviewed to ensure its
continued effectiveness.
The Company maintains well-defined policies, standard operating
procedures, authority matrices and control mechanisms across all key business and
financial processes. These controls are designed to provide reasonable assurance regarding
the reliability of financial reporting, effectiveness and efficiency of operations,
safeguarding of assets against unauthorized use or disposition, compliance with applicable
laws, regulations and internal policies, and timely identification and mitigation of
operational and financial risks.
The internalcontrol environment is supported by periodic management
reviews, risk assessment processes, monitoring mechanisms and internal audit evaluations.
Significant observations and recommendations arising from internal audits are reviewed by
the Audit Committee and corrective as well as preventive actions are implemented wherever
necessary. Key financial controls are tested periodically to assess their operating
effectiveness, and appropriate measures are taken to strengthen controls in areas
requiring improvement.
Based on the evaluation carried out during the year, the Board is of
the opinion that the Company's internal financial controls were adequate and
operating effectively as at March 31,2026. No material weaknesses were identified in the
design or operation of such controls. Further, during the year under review, no instances
of fraud were detected or reported to the Audit Committee.
Directors' Responsibility Statement
Pursuant to Section 134(5) of the Act, the Board of Directors, to the
best of their knowledge and ability, in respect of the year ended March 31,2026, confirm
that:
(a) in the preparation of the annual accounts, the applicable
accounting standards have been followed and that there are no material departures;
(b) they have selected such accounting policies and applied them
consistently and made judgments and estimates that are reasonable and prudent so as to
give a true and fair view of the state of affairs of the Company at the end of the
financial year and of the profit of the Company for that period;
(c) they took proper and sufficient care for the maintenance of
adequate accounting records in accordance with the provisions of this Act for safeguarding
the assets of the Company and for preventing and detecting fraud and other irregularities;
(d) they prepared the annual accounts on a going concern basis;
(e) they laid down internal financial controls to be followed by the
Company and that such internal financial controls are adequate and were operating
effectively; and
(f) they devised proper systems to ensure compliance with the
provisions of all applicable laws and that such systems were adequate and operating
effectively.
Auditor's and Auditor's Report Statutory Auditors
The Board at its meeting held on May 30, 2025 followed by Shareholders
approval at the 50th AGM held on August 14, 2025 appointed M/s. Kastury &
Talati, Chartered Accountants (Firm Reg. No. 104908W) as Statutory Auditor of the Company
for a period of five (5) years i.e. from the conclusion of the 50th AGM held on
August 14, 2025 until the conclusion of 55th AGM to be held in the FY 2030 at a
remuneration mutually agreed upon by the Board of Directors and the Statutory Auditor.
The Report given by the Auditors on the financial statements of the
Company is part of this Report. There has been no modified opinion, qualification,
reservation, adverse remark or disclaimer given by the Auditors in their Report during the
year under review and the observations and comments given in the report of the Statutory
Auditors read together with Notes to Accounts are self-explanatory and hence do not call
for any further explanation or comments under Section 134 (f)(i) of the Act.
Cost Auditor
As per the requirement of Central Government and pursuant to Section
148 of the Act read with the Companies (Cost Records and Audit) Rules, 2014 as amended
from time to time, your Company has been carrying out audit of cost records every year.
The Board of Directors on the recommendation of Audit Committee, at
their meeting held on May 15, 2026 appointed M/s. Aatish & Associates, Cost &
Management Accountants, Mumbai, (FRN: 006726/ Membership No. 30105) as the Cost Auditor to
conduct audit of the cost records of the Company for FY 202627. The Company is seeking the
approval of the Members for the remuneration to be paid to M/s. Aatish & Associates,
Cost & Management Accountant for the FY ending March 31,2027.
M/s. Aatish & Associates have confirmed that they are free from
disqualification specified under Section 141(3) and proviso to Section 148(3) read with
Section 141(4) of the Act and that the appointment meets the requirements of Section
141(3)(g) of the Act. They have further confirmed their independent status and an
arm's length relationship with the Company.
The relevant Cost Audit Report for the FY 2024-25 was filed with
Ministry of Corporate Affairs on August 29, 2025 in Form CRA-4.
Secretarial Auditor & Secretarial Audit Report
Pursuant to the provisions of Section 204 of the Act, the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, and Regulation 24A of
Listing Regulations, Mr. Virendra G. Bhatt, Practicing Company Secretary (C.P. No.: 124)
has been appointed as Secretarial Auditor of the Company for a period of five (5) years
from FY 2025-26 till FY 2029-30 and same was approved by shareholders at the 50th
AGM held on August 14, 2025.
The Secretarial Audit Report in Form MR- 3 for the Financial Year ended
March 31, 2026 is annexed as Annexure 3.
There are no qualification, reservation, adverse remark or disclaimer
given by the Secretarial auditor in their report for the year under review.
Reporting of Fraud
During the year under review, the Statutory Auditor, Cost Auditor and
Secretarial Auditor have not reported any instances of frauds committed in the Company by
its officers or employees, to the Audit Committee under Section 143(12) of the Act details
of which needs to be mentioned in this Annual Report.
Compliance with Secretarial Standards
In terms of Section 118(10) of the Act, the Company is complying with
the Secretarial Standards issued by the Institute of Company Secretaries of India (ICSI)
with respect to Meetings of Board of Directors and General Meetings and such systems were
adequate and operating effectively.
Particulars of Employees and Key Managerial Personnel
The statement containing particulars of employees as required under
Section 197 of the Act read with Rule 5(2) of the Companies (Appointment and Remuneration
of Managerial Personnel) Rules, 2014, as amended, is annexed to this Report as Annexure
4.
Employee Stock Option Scheme
Your Company has adopted CHEMBOND Employees Stock Option Scheme 2025
("CHEMBOND ESOP 2025") for granting options to eligible employees of your
Company as approved by the Members of your Company at the 50th AGM held on
August 14, 2025.
The applicable disclosures as required under the SEBI (Share Based
Employee Benefits and Sweat Equity) Regulations, 2021 and the details of stock options as
at March 31,2026 under the ESOP 2025 are set out in the Report as Annexure 5.
Corporate Social Responsibility
In accordance with the provisions of Section 135 of the Act read with
the Companies (Corporate Social Responsibility Policy) Rules, 2014, as amended from time
to time, the Board of Directors has constituted a Corporate Social Responsibility (CSR)
Committee and adopted a CSR Policy to guide the Company's CSR initiatives. The
Company continues to undertake and contribute towards CSR activities in compliance with
the applicable provisions of the Act.
The CSR Policy is reviewed and updated periodically to align with the
evolving regulatory framework, including the requirements of the Companies (Corporate
Social Responsibility Policy) Amendment Rules, 2021. The Policy is available on the
Company's website at https:// chembond.in/all-policies/.
The Company's CSR philosophy is driven by its commitment to
creating sustainable value for society through initiatives that emphasize scale,
measurable impact and long-term sustainability. Details relating to the composition, terms
of reference and meetings of the CSR Committee are provided in the Corporate Governance
Report forming part of this Annual Report.
During FY 2025-26, the Company spent Rs 21.55 lakhs towards CSR
activities through Visan Trust. The Company has identified key focus areas for its CSR
interventions in line with the objectives set out in its CSR Policy. Further details of
the CSR initiatives undertaken during the year are provided in the Annual Report on CSR
Activities annexed to this Report as Annexure 6.
Business Responsibility and Sustainability Report
The Business Responsibility and Sustainability Report for the year
ended March 31, 2026 as stipulated under Regulation 34(f) of the Listing Regulations is
not applicable to the Company.
Prevention, Prohibition and Redressal of Sexual Harassment of Women
The Company is committed to providing and maintaining a safe, secure
and inclusive work environment that is free from sexual harassment and discrimination. In
compliance with the provisions of the Sexual Harassment of Women at Workplace (Prevention,
Prohibition and Redressal) Act, 2013 ("POSH Act"), the Company has adopted a
comprehensive Anti-Sexual Harassment Policy. The Policy on Prevention of Sexual Harassment
at Workplace is available on the Company's website at
https://chembond.in/all-policies/.
An Internal Complaints Committee (ICC) has been duly constituted to
address and redress complaints relating to sexual harassment in accordance with the
provisions of the POSH Act. The Policy extends to all employees of the Company, including
permanent, contractual, temporary employees and trainees. The Company also conducts
awareness and training programmes to educate employees on the provisions of the POSH Act
and to promote a respectful and dignified workplace culture.
During the financial year under review, no complaint pertaining to
sexual harassment was received by the ICC.
Compliance with Maternity Benefit Act, 1961
The Company is compliant with the applicable provisions of the
Maternity Benefit Act, 1961 and has policies, systems and processes in place to ensure
ongoing compliance.
Policies and Disclosure Requirements
Pursuant to the provisions of the Act and the Listing Regulations, the
Company has adopted all applicable policies and procedures. These policies are available
on the Company's website at https://chembond.in/all- policies/.
All Directors and Senior Management Personnel have affirmed compliance
with the Company's Code of Conduct for the fy 2025-26.
The Company's policy on the appointment and remuneration of
Directors, including the criteria for determining qualifications, positive attributes and
independence of Directors, as well as other matters specified under Section 178(3) of the
Act, is embodied in the Nomination and Remuneration Policy. Details of the Policy are
provided in the Corporate Governance Report forming part of this Annual Report.
Particulars of Related Party Transactions
All related party transactions entered into by the Company during the
financial year under review were undertaken in the ordinary course of business and on an
arm's length basis. Accordingly, such transactions did not attract the provisions of
Section 188(1) of the Act. Consequently, the disclosure in Form AOC-2, as prescribed under
the Act, is not applicable to the Company for FY 2025-26 and does not form part of this
Report.
The Company has complied with the applicable requirements relating to
related party transactions and has made appropriate disclosures in the Notes to the
Financial Statements in accordance with the provisions of Indian Accounting Standard (Ind
AS) 24 - Related Party Disclosures.
The Board has approved a Policy on Related Party Transactions to ensure
transparency and/ compliance with the applicable statutory and regulatory requirements.
The said Policy is available on the Company's website at https://chembond.in/all-
policies/.
The Conservation of Energy, Technology Absorption, Foreign Exchange
Earnings and Outgo
The particulars relating to conservation of energy, technology
absorption and foreign exchange earnings and outgo, as required to be disclosed under
Section 134(3)(m) of the Act read with Rule 8(3) of the Companies (Account) Rules, 2014,
as amended from time to time, are provided in Annexure 7.
Research and Development
The Company recognizes the need to have well equipped R&D
facilities to meet customer requirements and in developing cutting edge products. As a
natural corollary your Company continues to invest in a comprehensive R&D programme
leveraging its world- class infrastructure, benchmarked processes, state- of-the-art
technology and a business-focused R&D strategy.
The Company has spent approx. Rs 359.12 lakhs during the year under
report on research and development.
Transfer to Investor Education and Protection Fund
Pursuant to the provisions of Section 124 of the Act, dividends
remaining unpaid or unclaimed for a period of seven(7) consecutive years from the date of
their transfer to the Company's Unpaid Dividend Account are required to be
transferred to the Investor Education and Protection Fund ("IEPF") established
by the Central Government. Further, in accordance with Section 124 of the Act read with
the IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from
time to time, all shares in respect of which dividends have remained unpaid or unclaimed
for seven consecutive years or more are required to be transferred to the demat account of
the IEPF Authority.
During the year under review, the Company transferred the requisite
shares to the demat account of the IEPF Authority in compliance with the applicable
statutory provisions. Prior to such transfer, the Company had individually communicated
with the concerned shareholders whose shares were liable to be transferred and had also
published notices in newspapers in accordance with the prescribed requirements. The
details of such shareholders and the shares transferred to the IEPF Authority have been
uploaded on the Company's website for the information of stakeholders.
Members and claimants whose shares and/or unclaimed dividend amounts
have been transferred to the IEPF Authority may claim the same by submitting an
application in Form IEPF-5, available on the IEPF website (www.iepf.gov.in), in accordance
with the prescribed procedure. As per the IEPF Rules, only one consolidated claim can be
filed by a claimant in a financial year.
IEPF Saksham Niveshak Campaign
The Company undertook a 100-day investor awareness campaign
"Saksham Niveshak", as initiated by the Investor Education and Protection Fund
Authority, Ministry of Corporate Affairs, during the period from July 28, 2025 to November
6, 2025.
The Company has also initiated actions under the second Saksham
Niveshak Campaign which started from April 1,2026.
Material Changes and Commitment
Except as disclosed elsewhere in the Report, there have been no
material changes and commitment affecting, the financial position of your Company, which
have occurred between the end of the financial year of the Company and the date of this
Report.
Significant and Material Orders
During the year under review, there has been one pending litigation
against the Company and its Directors whose order is yet to be received. The matter is
explained in detail in the Corporate Governance Section of the Annual Report. Except this
there has been no significant and material order passed by the Regulators or Courts or
Tribunals impacting the going concern status of the Company and its future operations.
Proceedings Pending under the Insolvency and Bankruptcy Code
There are no such proceedings or appeals pending and no applications
has been filed under Insolvency and Bankruptcy Code, 2016 during the year under review and
from the end of the financial year upto the date of this report.
The details of difference between amount of the valuation done at the
time of One-time settlement and the valuation done while taking loan from the Banks or
Financial Institutions
No such instance of one-time settlement or valuation was done while
taking or discharging loan from the Banks/ Financial Institutions occurred during the
year.
Acknowledgements
Your Board wishes to place on record their appreciation and acknowledge
with gratitude the support and cooperation extended by customers, vendors, employees,
government authorities, bankers, and members during the year under review and look forward
to their continued support.
| On behalf of the Board |
| sd/- |
| Sameer V. Shah |
| Chairman & Managing Director |
| DIN:00105721 |
| Navi Mumbai |
| May 15,2026 |
|